We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFT
2476
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
$8K ﹤0.01%
+504
New +$7.44K
DLA
2477
DELISTED
Delta Apparel Inc.
DLA
$8K ﹤0.01%
242
-484
-67% -$13K
TESS
2478
DELISTED
Tessco Technologies Inc
TESS
$8K ﹤0.01%
660
+548
+489% +$6.96K
BRMK
2479
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$8K ﹤0.01%
+600
New +$6.67K
HZN
2480
DELISTED
Horizon Global Corporation
HZN
$8K ﹤0.01%
+2,212
New +$8.19K
CEA
2481
DELISTED
China Eastern Airlines
CEA
$8K ﹤0.01%
+300
New +$7.62K
RMO
2482
DELISTED
Romeo Power, Inc.
RMO
$8K ﹤0.01%
800
+600
+300% +$5.94K
MCA
2483
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
$8K ﹤0.01%
+572
New +$8.14K
ALTA
2484
DELISTED
Altabancorp
ALTA
$8K ﹤0.01%
263
-23
-8% -$674
ENT
2485
DELISTED
Global Eagle Entertainment Inc.
ENT
$8K ﹤0.01%
627
+1
+0.2% +$14
LBY
2486
DELISTED
Libbey, Inc.
LBY
$8K ﹤0.01%
5,843
+5,743
+5,743% +$10.8K
ELGX
2487
DELISTED
Endologix Inc
ELGX
$8K ﹤0.01%
4,796
+1,060
+28% +$2.97K
MACK
2488
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$8K ﹤0.01%
2,533
-309
-11% -$1.24K
PDLI
2489
DELISTED
PDL BioPharma, Inc.
PDLI
$8K ﹤0.01%
2,681
-6,147
-70% -$17.8K
CEMI
2490
DELISTED
Chembio diagnostics, Inc.
CEMI
$8K ﹤0.01%
1,771
+1,487
+524% +$7.25K
WBK
2491
DELISTED
Westpac Banking Corporation
WBK
$8K ﹤0.01%
451
+184
+69% +$3.33K
IMH
2492
DELISTED
Impac Mortgage Holdings Inc.
IMH
$8K ﹤0.01%
1,455
+944
+185% +$6.14K
RESI
2493
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$8K ﹤0.01%
640
-4,952
-89% -$58.8K
ACTG icon
2494
Acacia Research
ACTG
$470M
$7K ﹤0.01%
2,804
+689
+33% +$1.89K
AMED
2495
DELISTED
Amedisys
AMED
$7K ﹤0.01%
40
-496
-93% -$73.8K
BCML icon
2496
BayCom
BCML
$333M
$7K ﹤0.01%
293
-460
-61% -$10.2K
BRO icon
2497
Brown & Brown
BRO
$23.9B
$7K ﹤0.01%
189
-1,411
-88% -$53K
BSRR icon
2498
Sierra Bancorp
BSRR
$525M
$7K ﹤0.01%
243
+56
+30% +$1.54K
CAC icon
2499
Camden National
CAC
$976M
$7K ﹤0.01%
149
-369
-71% -$16.3K
CFBK icon
2500
CF Bankshares
CFBK
$236M
$7K ﹤0.01%
+524
New +$6.98K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.